Purchase, NYCIK 19733234 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
26 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Astrazeneca PLC | 290.7K | $51.01M | 25.0% | +47.5K | Added |
| 2 | Novartis AG | 172.1K | $23.73M | 11.6% | +400 | Added |
| 3 | Hsbc Hldgs PLC | 293.4K | $23.08M | 11.3% | +112.9K | Added |
| 4 | Sony Group Corp |
| 772.1K |
| $19.77M |
| 9.7% |
| −41.0K |
| Reduced |
| 5 | Novo-Nordisk A S | 330.3K | $16.80M | 8.2% | +165.0K | Added |
| 6 | Canadian Natl Ry Co | 156.0K | $15.42M | 7.6% | +401 | Added |
| 7 | Rio Tinto PLC | 163.8K | $13.11M | 6.4% | −29.2K | Reduced |
| 8 | Stmicroelectronics N V | 483.1K | $12.53M | 6.1% | −68.9K | Reduced |
| 9 | Shell PLC | 163.9K | $12.04M | 5.9% | 0 | Held |
| 10 | Sap Se | 38.8K | $9.43M | 4.6% | +875 | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio